Dabur Q2 Review: Systematix Maintains 'Hold' On Unconvincing Outlook — Check New Target Price

While Dabur expects H2 FY26 topline growth to pick up to high-single digits, it cautioned that GST-related trade disruption had spilled over into October. The GST tremors also hampered winter-portfolio channel loading – while this will now happen in Q3 FY26, Dabur noted it would maintain distributor-level stock pipeline at 22 days, which the brokerage believes can likely limit the Q3 upside from loading..NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Systematix Report.Dabur India Ltd.’s recent growth trends have been underwhelming, especially in Q2 FY26 off an exceptionally weak base quarter in healthcare and beverages, notwithstanding the twin impact of GST and seasonality. Categories of beverages, oral care and hair care continue to contend with elevated competitive intensity, necessitating high consumer/ trade incentives. However, performance can gradually revive going forward, aided by-sustained rural rebound (7-8% growth for Dabur) with eventual urban recovery,share gains in home and personal care categories, and distribution expansion, Dabur maintains strong positions in legacy ayurvedic products (honey, chyawanprash), premium launches/ format extensions in HPC/ Healthcare (Chyawanprash variants now contributing 20-30% to brand sales), andan F&B recovery with launches that plug portfolio gaps (Activ coconut water). .We expect some margin support from better mix, cost savings and pricing power in key brands. Valuation: We marginally trim our FY26E-FY28E revenue/ EPS estimates by 1-3%, and build FY25-FY28E revenue/EPS CAGR of 6%/10%. We maintain Hold rating on the stock; we roll forward valuation to September-2027E EPS (vs June-2027) and value Dabur on a P/E of 44x, in line with its current one-year forward multiple and at a discount to peer Marico, resulting in a revised target price of Rs 550 (earlier Rs 565)..Click on the attachment to read the full report:.Dabur Q2 Results: Profit Rises 7% On Gains In Consumer Care Segment; Food Business Flat.DISCLAIMERThis report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Dabur Q2 Review: Systematix Maintains 'Hold' On Unconvincing Outlook — Check New Target Price

The brokerage marginally trims Dabur's FY26E-FY28E revenue/ EPS estimates by 1-3%, and build FY25-FY28E revenue/EPS CAGR of 6%/10%.

NDTV Profit

NDTV Profit

Follow Us

DISCOVER US FASTER

DOWNLOAD THE APP